Hervé Brailly, CEO, is invited to the panel discussion "French Public Markets – Breakthrough Technologies Panel".
Zurich,Switzerland
More info
Innate Pharma S.A., a biopharmaceutical company specialized in cancer immuno- therapeutics, today announced the achievement of the first milestone in their collaboration with Novo Nordisk A/S in Denmark.
| Download Area |
|---|
| PR in english |